Literature DB >> 35852758

Recent Update on Active Biological Molecules in Generating the Anticancerous Therapeutic Potential of Garcinia mangostana.

Neha Verma1, Soumya Pandit1, Anil Kumar2, Gulab Yadav3, Shiv Kumar Giri3, Dibyajit Lahiri4, Zulhisyam Abdul Kari5, Ram Prasad6.   

Abstract

The Garcinia mangostana Linn (Mangosteen) is also called as "Queen of Fruits" in Malaysia. It is found in the region of Southeast Asia. It is a medicinal plant that has been used to treat cancer in a variety of cell lines. The mangosteen pericarp possesses distinctive biological properties like anticancer or antitumoral and antioxidant. It has a distinct sweet and sour taste, rich in biological compounds like xanthones. It exhibits various properties like apoptotic in tumor cells which leads to the suppression of their growth and results in their various sizes. The primary purpose of this review article is to summarize the valuable results covered by the researchers so far in the Garcinia mangostana extract and its compound like xanthones. Our focus was to explain the role of the phytoconstituent molecules in invading the cancer pathways to combat the expansion of cells. Furthermore, we still feel that there is a scope for more in silico and in vivo studies to understand and identify the specific site of action in tumoral cells and their mechanistic pathways. In conclusion, Garcinia mangostana can act as an anticancer agent by attacking various molecular pathways.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Anticancer; Biological properties; Garcinia mangostana; Mangosteen; Xanthones

Mesh:

Substances:

Year:  2022        PMID: 35852758     DOI: 10.1007/s12010-022-04031-2

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   3.094


  33 in total

1.  Acetyl- and O-alkyl- derivatives of β-mangostin from Garcinia mangostana and their anti-inflammatory activities.

Authors:  Thiruventhan Karunakaran; Gwendoline Cheng Lian Ee; Intan Safinar Ismail; Siti Mariam Mohd Nor; Nor Hisam Zamakshshari
Journal:  Nat Prod Res       Date:  2017-07-17       Impact factor: 2.861

2.  Xanthones with antimalarial activity from Garcinia dulcis.

Authors:  K Likhitwitayawuid; W Chanmahasathien; N Ruangrungsi; J Krungkrai
Journal:  Planta Med       Date:  1998-04       Impact factor: 3.352

3.  Mangostanaxanthones III and IV: advanced glycation end-product inhibitors from the pericarp of Garcinia mangostana.

Authors:  Hossam M Abdallah; Hany M El-Bassossy; Gamal A Mohamed; Ali M El-Halawany; Khalid Z Alshali; Zainy M Banjar
Journal:  J Nat Med       Date:  2016-10-13       Impact factor: 2.343

4.  A novel xanthone dimer derivative with antibacterial activity isolated from the bark of Garcinia mangostana.

Authors:  Weiyi Wang; Yanyan Liao; Xiaomei Huang; Chao Tang; Peng Cai
Journal:  Nat Prod Res       Date:  2017-11-13       Impact factor: 2.861

Review 5.  Anticarcinogenic Effects of α-Mangostin: A Review.

Authors:  Kuo-Jun Zhang; Qin-Lan Gu; Kan Yang; Xian-Jun Ming; Jin-Xin Wang
Journal:  Planta Med       Date:  2016-11-04       Impact factor: 3.352

6.  Single dose oral pharmacokinetic profile of α-mangostin in mice.

Authors:  Atulkumar Ramaiya; Gongbo Li; Sakina M Petiwala; Jeremy J Johnson
Journal:  Curr Drug Targets       Date:  2012-12       Impact factor: 3.465

7.  Antioxidant xanthones from the pericarp of Garcinia mangostana (Mangosteen).

Authors:  Hyun-Ah Jung; Bao-Ning Su; William J Keller; Rajendra G Mehta; A Douglas Kinghorn
Journal:  J Agric Food Chem       Date:  2006-03-22       Impact factor: 5.279

8.  Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group.

Authors:  Richard Herrmann; György Bodoky; Thomas Ruhstaller; Bengt Glimelius; Emilio Bajetta; Johannes Schüller; Piercarlo Saletti; Jean Bauer; Arie Figer; Bernhard Pestalozzi; Claus-Henning Köhne; Walter Mingrone; Salomon M Stemmer; Karin Tàmas; Gabriela V Kornek; Dieter Koeberle; Susanne Cina; Jürg Bernhard; Daniel Dietrich; Werner Scheithauer
Journal:  J Clin Oncol       Date:  2007-06-01       Impact factor: 44.544

9.  Metabolic profiling of Garcinia mangostana (mangosteen) based on ripening stages.

Authors:  Anjaritha A R Parijadi; Sastia P Putri; Sobir Ridwani; Fenny M Dwivany; Eiichiro Fukusaki
Journal:  J Biosci Bioeng       Date:  2017-09-29       Impact factor: 2.894

10.  Cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line metastatic pancreatic cancer: a multicentre phase II study.

Authors:  F Kullmann; S Hollerbach; M M Dollinger; J Harder; M Fuchs; H Messmann; J Trojan; E Gäbele; A Hinke; C Hollerbach; E Endlicher
Journal:  Br J Cancer       Date:  2009-03-17       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.